Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

乳腺癌中紫杉类药物临床应用专家共识

2020-03-16 中国肿瘤科相关专家小组（统称） 中国医学前沿杂志（电子版）.2020,12(3):31-40.

乳腺癌紫杉类药物

乳腺癌是女性最常见的恶性肿瘤，严重威胁女性健康。紫杉类药物是乳腺癌治疗中最常用的药物之一。乳腺癌中 紫杉类药物临床应用专家共识专家委员会基于循证医学证据，深入探讨乳腺癌中紫杉类药物的临床应用，形成了《

中文标题：

乳腺癌中紫杉类药物临床应用专家共识

英文标题：

Expert consensus on the clinical practice of taxanes for the treatment of breast cancer

发布机构：

中国肿瘤科相关专家小组（统称）

发布日期：

2020-03-16

简要介绍：

乳腺癌是女性最常见的恶性肿瘤，严重威胁女性健康。紫杉类药物是乳腺癌治疗中最常用的药物之一。乳腺癌中 紫杉类药物临床应用专家共识专家委员会基于循证医学证据，深入探讨乳腺癌中紫杉类药物的临床应用，形成了《 乳腺癌 中紫杉类药物临床应用专家共识》，以指导临床医生合理用药，进一步规范诊疗行为。

相关资料下载：
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=c75ec1c0018823b3, title=乳腺癌中紫杉类药物临床应用专家共识, enTitle=Expert consensus on the clinical practice of taxanes for the treatment of breast cancer, guiderFrom=中国医学前沿杂志（电子版）.2020,12(3):31-40., authorId=0, author=, summary=乳腺癌是女性最常见的恶性肿瘤，严重威胁女性健康。紫杉类药物是乳腺癌治疗中最常用的药物之一。乳腺癌中 紫杉类药物临床应用专家共识专家委员会基于循证医学证据，深入探讨乳腺癌中紫杉类药物的临床应用，形成了《, cover=https://img.medsci.cn/2020324/1584979604756_2020535.jpg, journalId=0, articlesId=null, associationId=747, associationName=中国肿瘤科相关专家小组（统称）, associationIntro=null, copyright=0, guiderPublishedTime=Mon Mar 16 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>乳腺癌是女性最常见的恶性肿瘤，严重威胁女性健康。紫杉类药物是乳腺癌治疗中最常用的药物之一。乳腺癌中 紫杉类药物临床应用专家共识专家委员会基于循证医学证据，深入探讨乳腺癌中紫杉类药物的临床应用，形成了《 乳腺癌 中紫杉类药物临床应用专家共识》，以指导临床医生合理用药，进一步规范诊疗行为。</p> </div> </div> </div>, tagList=[TagDto(tagId=285, tagName=乳腺癌), TagDto(tagId=94932, tagName=紫杉类药物)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=285, guiderKeyword=乳腺癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4861, appHits=311, showAppHits=24, pcHits=790, showPcHits=4578, likes=2, shares=14, comments=15, approvalStatus=1, publishedTime=Tue Mar 24 00:32:09 CST 2020, publishedTimeString=2020-03-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Mar 24 00:07:18 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:03:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1067660, encodeId=4a34106e66050, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69ff5642636, createdName=ms4000000670558531, createdTime=Sat Nov 06 20:55:01 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922086, encodeId=218e92208657, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210202/b6e581be368a46b08d225d5c467a6a89/f7091bf50539458b9ebc0dd9e0ae1937.jpg, createdBy=9e1d5318884, createdName=148a3cb9m62(暂无昵称), createdTime=Tue Feb 02 00:16:44 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920348, encodeId=76a3920348c1, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cibvDoiaBjtMpvuHDS6uW3ziaWapLVViatVe7KDMGUiaapbzFYGVO8ICqNDialpQpiaxHp7XNq6VuViaUtARdW2m1eAogA/132, createdBy=59db2552849, createdName=silently00, createdTime=Wed Jan 27 17:49:13 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902307, encodeId=f5bd90230ebc, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/708b7846d49342dd913bbae6a94e06d3/c0c909d2b3374ae0a1042261447b3b1d.jpg, createdBy=9c1e5438518, createdName=夏天的一缕清风, createdTime=Wed Nov 25 22:15:55 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898621, encodeId=ff4e8986217f, content=很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Thu Nov 12 09:07:59 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2021-11-06 ms4000000670558531

    学习中

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1067660, encodeId=4a34106e66050, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69ff5642636, createdName=ms4000000670558531, createdTime=Sat Nov 06 20:55:01 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922086, encodeId=218e92208657, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210202/b6e581be368a46b08d225d5c467a6a89/f7091bf50539458b9ebc0dd9e0ae1937.jpg, createdBy=9e1d5318884, createdName=148a3cb9m62(暂无昵称), createdTime=Tue Feb 02 00:16:44 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920348, encodeId=76a3920348c1, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cibvDoiaBjtMpvuHDS6uW3ziaWapLVViatVe7KDMGUiaapbzFYGVO8ICqNDialpQpiaxHp7XNq6VuViaUtARdW2m1eAogA/132, createdBy=59db2552849, createdName=silently00, createdTime=Wed Jan 27 17:49:13 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902307, encodeId=f5bd90230ebc, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/708b7846d49342dd913bbae6a94e06d3/c0c909d2b3374ae0a1042261447b3b1d.jpg, createdBy=9c1e5438518, createdName=夏天的一缕清风, createdTime=Wed Nov 25 22:15:55 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898621, encodeId=ff4e8986217f, content=很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Thu Nov 12 09:07:59 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2021-02-02 148a3cb9m62(暂无昵称)

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1067660, encodeId=4a34106e66050, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69ff5642636, createdName=ms4000000670558531, createdTime=Sat Nov 06 20:55:01 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922086, encodeId=218e92208657, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210202/b6e581be368a46b08d225d5c467a6a89/f7091bf50539458b9ebc0dd9e0ae1937.jpg, createdBy=9e1d5318884, createdName=148a3cb9m62(暂无昵称), createdTime=Tue Feb 02 00:16:44 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920348, encodeId=76a3920348c1, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cibvDoiaBjtMpvuHDS6uW3ziaWapLVViatVe7KDMGUiaapbzFYGVO8ICqNDialpQpiaxHp7XNq6VuViaUtARdW2m1eAogA/132, createdBy=59db2552849, createdName=silently00, createdTime=Wed Jan 27 17:49:13 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902307, encodeId=f5bd90230ebc, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/708b7846d49342dd913bbae6a94e06d3/c0c909d2b3374ae0a1042261447b3b1d.jpg, createdBy=9c1e5438518, createdName=夏天的一缕清风, createdTime=Wed Nov 25 22:15:55 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898621, encodeId=ff4e8986217f, content=很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Thu Nov 12 09:07:59 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2021-01-27 silently00

    学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1067660, encodeId=4a34106e66050, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69ff5642636, createdName=ms4000000670558531, createdTime=Sat Nov 06 20:55:01 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922086, encodeId=218e92208657, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210202/b6e581be368a46b08d225d5c467a6a89/f7091bf50539458b9ebc0dd9e0ae1937.jpg, createdBy=9e1d5318884, createdName=148a3cb9m62(暂无昵称), createdTime=Tue Feb 02 00:16:44 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920348, encodeId=76a3920348c1, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cibvDoiaBjtMpvuHDS6uW3ziaWapLVViatVe7KDMGUiaapbzFYGVO8ICqNDialpQpiaxHp7XNq6VuViaUtARdW2m1eAogA/132, createdBy=59db2552849, createdName=silently00, createdTime=Wed Jan 27 17:49:13 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902307, encodeId=f5bd90230ebc, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/708b7846d49342dd913bbae6a94e06d3/c0c909d2b3374ae0a1042261447b3b1d.jpg, createdBy=9c1e5438518, createdName=夏天的一缕清风, createdTime=Wed Nov 25 22:15:55 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898621, encodeId=ff4e8986217f, content=很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Thu Nov 12 09:07:59 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2020-11-25 夏天的一缕清风

    学习中

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1067660, encodeId=4a34106e66050, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69ff5642636, createdName=ms4000000670558531, createdTime=Sat Nov 06 20:55:01 CST 2021, time=2021-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=922086, encodeId=218e92208657, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210202/b6e581be368a46b08d225d5c467a6a89/f7091bf50539458b9ebc0dd9e0ae1937.jpg, createdBy=9e1d5318884, createdName=148a3cb9m62(暂无昵称), createdTime=Tue Feb 02 00:16:44 CST 2021, time=2021-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=920348, encodeId=76a3920348c1, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/cibvDoiaBjtMpvuHDS6uW3ziaWapLVViatVe7KDMGUiaapbzFYGVO8ICqNDialpQpiaxHp7XNq6VuViaUtARdW2m1eAogA/132, createdBy=59db2552849, createdName=silently00, createdTime=Wed Jan 27 17:49:13 CST 2021, time=2021-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902307, encodeId=f5bd90230ebc, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201125/708b7846d49342dd913bbae6a94e06d3/c0c909d2b3374ae0a1042261447b3b1d.jpg, createdBy=9c1e5438518, createdName=夏天的一缕清风, createdTime=Wed Nov 25 22:15:55 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898621, encodeId=ff4e8986217f, content=很受用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=226c4799349, createdName=654568956, createdTime=Thu Nov 12 09:07:59 CST 2020, time=2020-11-12, status=1, ipAttribution=)]
    2020-11-12 654568956

    很受用

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 CAP临床指南：乳腺癌雌激素和孕激素受体检测

美国病理学家协会(CAP,College of American Pathologists) · 2020-01-13

中国乳腺癌靶向治疗药物安全性管理专家共识

中华医学会肿瘤学分会 · 2019-12-30

乳腺癌术后乳房重建中国专家共识（2019版）

中华医学会外科学分会 乳腺外科学组 · 2019-11-30

男性乳腺癌治疗药物开发：行业指南草案（FDA）

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2019-10-31

中国抗癌协会乳腺癌诊治指南与规范（2019年版）

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2019-08-30

2019 中国女性乳腺癌筛查指南

中国抗癌协会(Chinese Anti-cancer Association) · 2019-05-15

拓展阅读

乳腺癌HER2检测指南(2009版)

中国肿瘤科相关专家小组（统称） · 2009-12-01

2010 乳腺癌骨转移和骨相关疾病临床诊疗专家共识（2010版）

乳腺癌骨转移和骨相关疾病临床诊疗专家组 · 2010-01-01

2010 SBI/ACR推荐建议：乳腺癌影像学筛查

乳腺影像学会(SBI,Society of Breast Imaging) · 2010-01-20

2010 人表皮生长因子受体2阳性乳腺癌临床诊疗专家共识

中国抗癌协会乳腺癌专业委员会(CACA-CBCS,Chinese Anti-Cancer Association, Committee of Breast Cancer Society) · 2010-02-01

2010 ASCO-CAP指南：乳腺癌患者雌激素和雄激素受体的免疫组化检测

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-04-19

2010 ASCO指南：激素受体阳性乳腺癌妇女的辅助内分泌治疗

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2010-07-12

Baidu
map
Baidu
map
Baidu
map